trans-autophosphorylation is among the most prevalent means of protein kinase activation, yet its molecular basis is poorly defined. In Toll-like receptor and interleukin-1 receptor signaling pathways, the kinase IRAK4 is recruited to the membrane-proximal adaptor MyD88 through death domain (DD) interactions, forming the oligomeric Myddosome and mediating NF-kB activation. Here we show that unphosphorylated IRAK4 dimerizes in solution with a K D of 2.5 mM and that Myddosome assembly greatly enhances IRAK4 kinase domain (KD) autophosphorylation at sub-K D concentrations. The crystal structure of the unphosphorylated IRAK4 KD dimer captures a conformation that appears to represent the actual trans-autophosphorylation reaction, with the activation loop phosphosite of one IRAK4 monomer precisely positioned for phosphotransfer by its partner. We show that dimerization is crucial for IRAK4 autophosphorylation in vitro and liganddependent signaling in cells. These studies identify a mechanism for oligomerization-driven allosteric autoactivation of IRAK4 that may be general to other kinases activated by autophosphorylation.
INTRODUCTION
Toll-like receptors (TLRs) and interleukin-1 (IL-1) receptors (IL1Rs) form a large family of transmembrane receptors that function in inflammatory and innate immune signaling ( Netea et al., 2012) . TLR family members are expressed in a variety of immune cells, each recognizing a distinct pathogen-associated molecular pattern, such as dsRNA, lipopolysaccharides, flagellin, and unmethylated CpG DNA, using extracellular leucine-rich repeat (LRR) domains. IL-1R family members recognize cognate agonistic cytokines such as IL-1b and IL-18 using extracellular immunoglobulin-like domains.
Structural information on TLR-ligand complexes reveals that LRR domains form similar M-shaped dimers that bring their C termini in close proximity to each other for signal initiation (Jin and Lee, 2008) . Crystal structures of a ternary complex comprised of IL-1R, the coreceptor IL-1RAcP, and IL-1b also demonstrate adjacent receptor and coreceptor C termini (Thomas et al., 2012; Wang et al., 2010) .
Members of the TLR and IL-1R families share a common cytoplasmic Toll/IL-1 receptor (TIR) domain that is essential for the initiation of intracellular signaling Netea et al., 2012) . Ligand binding promotes receptor oligomerization, resulting in juxtaposition of receptor TIR domains and recruitment of TIR-containing adaptor proteins. MyD88 is the most critical of these adaptors, being essential for IL-1R signaling and all TLR family members except TLR3. MyD88 recruits IL-1R-associated kinase (IRAK) family members, directly interacting with IRAK4, the most proximal IRAK, followed by the downstream kinases IRAK1 and IRAK2 . Activation of IRAKs results in formation of the TRAF6-TAK1-IKK signalosome for induction of the NF-kB pathway through polyubiquitination and kinase activation . The importance of MyD88 and IRAK4 in human diseases is exemplified by the prevalence of gain-offunction MyD88 mutations in diffuse large B cell lymphoma and Waldenströ m's macroglobulinemia (Ngo et al., 2011; Treon et al., 2012) , as well as loss-of-function MyD88 and IRAK4 mutations in children with recurrent pyogenic bacterial infections (Picard et al., 2003; von Bernuth et al., 2008) . MyD88 and IRAKs all contain a death domain (DD) ( Figure 1A ), a small a-helical domain that is highly prevalent in immune signaling complexes. Recruitment of IRAKs to MyD88 at the membrane is mediated by formation of an oligomeric DD scaffold, the Myddosome ). Our previous crystal structure of this scaffold revealed six MyD88 DDs, four IRAK4 DDs, and four IRAK2 DDs in a helically symmetrical sequential arrangement, providing insight into the elegant ordered assembly mechanism . Consistent with previous results, IRAK4 is the most upstream kinase in the pathway and is capable of autophosphorylation (Cheng et al., 2007; Li et al., 2002) . In addition, activated IRAK4 phosphorylates the activation loop of the downstream kinases IRAK1 and IRAK2, and MyD88 has been shown to promote this phosphorylation (Li et al., 2002) .
Many immune signaling complexes are now known to be higher-order assemblies that function as platforms for the activation of enzymes such as kinases and caspases (Wu, 2013) . Oligomerization-driven kinase activation may be mediated by autophosphorylation between two identical kinase molecules, likely in trans, although activation in cis has been implicated in other systems (Hu et al., 2013; Pellicena and Kuriyan, 2006) . In the case of IRAK4, a previous report implicated a cis-autophosphorylation mechanism, as wild-type (WT) IRAK4 was unable to phosphorylate a kinase-dead IRAK4 in their experiments (Cheng et al., 2007) .
Here, we used a combination of biochemistry, structural biology, and cell biology to reveal the molecular mechanism of IRAK4 autoactivation in the Myddosome. We showed that, surprisingly, unphosphorylated but not phosphorylated IRAK4 kinase domain (KD) is dimeric in solution with a modest dimerization constant. Previous structural studies on kinase autophosphorylation have been hampered by the transient nature of the process and relied on analysis of crystal lattice interactions. The crystal structure of the IRAK4 dimer revealed in this study instead allowed visualization of the native interactions in solution and permitted direct assessment of the role of IRAK4 dimerization in autophosphorylation and signaling. We demonstrated that IRAK4 undergoes trans-autophosphorylation rather than cis-autophosphorylation and that the asymmetric unphosphorylated IRAK4 KD dimer structure caught in an enzyme-substrate embrace represents a bona fide trans-autophosphorylation conformation that is promoted by the Myddosome. Our studies uncovered the proximityenhanced allosteric changes required for IRAK4 activation, FL-D311N at 6.4 mM, 4.8 mM, and 2.9 mM. Samples were run at five different speeds shown in rpm. Solid black lines correspond to the fitting of a monomer-dimer self-association model, which produced a dimerization K D of 2.5 ± 0.4 mM. Residuals are plotted below. See also Figure S1 .
which may represent a common mechanism of kinase transautophosphorylation.
RESULTS
Unphosphorylated, but Not Phosphorylated, IRAK4 Forms Dimers in Solution In order to capture the conformation of IRAK4 in the Myddosome during the initial autophosphorylation event, we reasoned that IRAK4 should be unphosphorylated. We therefore mutated the conserved Asp311 in the catalytic loop of full-length IRAK4 (IRAK4 FL ) to an Asn (IRAK4 ). This residue interacts with the attacking hydroxyl side chain of the substrate and is required for phosphotransfer (Nolen et al., 2004 Figure S1A , available online) with the goal of crystallization. Surprisingly, the size-exclusion chromatography (SEC) elution position of IRAK4 FL-D311N suggested that it was dimeric in solution ( Figure 1B) . When analyzed at different concentrations with SEC, IRAK4 FL-D311N eluted as single peaks rather than two distinct monomer and dimer peaks ( Figure 1C ). These peaks shifted from a dimeric position toward a monomeric one as the concentration was lowered, suggestive of a dynamic monomer/dimer equilibrium. We initially speculated that this dimerization was mediated by the DD of IRAK4, as many DDs are capable of homooligomerization . To test this hypothesis, we expressed and purified the IRAK4 KD containing the D311N mutant (IRAK4 ). Unexpectedly, IRAK4
KD-D311N also appeared dimeric by SEC analysis ( Figure 1B ), suggesting that IRAK4 dimerization is mediated by the KD. In agreement, a construct containing only the DD of IRAK4 has an experimental molecular mass of 11.5 kDa (3.0% error) as measured by multiangle light scattering (MALS), consistent with the 11.9 kDa calculated monomeric molecular mass ( Figure 1D ).
Because previously crystallized phosphorylated IRAK4 KD (p-IRAK4 KD ) was monomeric in solution (Kuglstatter et al., 2007) , we suspected that IRAK4 dimerization is affected by the phosphorylation state of the kinase. Therefore, we expressed and purified WT IRAK4 FL and IRAK4 KD from insect cells. IRAK4 FL was judged to be active by phosphorylation of an IRAK1 activation loop peptide ( Figure S1B ). The IRAK4 activation loop contains three phosphorylation sites, T342, T345, and S346 (Cheng et al., 2007) , with T345 as the prototypical phosphoresidue responsible for phosphorylation-dependent activation loop stabilization and kinase activation (Kuglstatter et al., 2007) . Western blot analysis with an antibody generated to react with an IRAK4 pT345-containing phosphopeptide showed that IRAK4 FL was natively phosphorylated and that this phosphorylation could be removed by treatment with lphosphatase ( Figure S1C ). Upon incubation of IRAK4 FL with ATP/Mg 2+ , T345 phosphorylation increased ( Figure S1D ). In comparison, IRAK4
FL-D311N had inappreciable levels of native T345 phosphorylation, and no additional phosphorylation was detected upon ATP/Mg 2+ incubation ( Figure S1D ). Liquid chromatography-tandem mass spectrometry (LC-MS/MS) revealed that IRAK4
FL is phosphorylated at T345, T342, and S346, with the most significant phosphorylation occurring at the prototypical T345 residue ( Figure S1E ). Importantly, both natively phosphorylated IRAK4 FL and IRAK4 KD appeared primarily monomeric when subjected to SEC analysis ( Figure 1B ). To further determine if IRAK4 phosphorylation states play a role in the monomer-to-dimer transition, we first dephosphorylated IRAK4
FL with l-phosphatase. Dephosphorylated IRAK4 FL was analyzed by mass spectrometry, and no residual phosphorylation was detected on any of the activation loop residues ( Figure S1E ). Dephosphorylated IRAK4 FL is dimeric in solution,
with an experimental molecular mass of 103.2 kDa (0.8% error) as measured by MALS ( Figure 1D ), approximating the calculated dimer molecular mass of 103.8 kDa. Incubation with ATP/Mg 2+ results in autophosphorylation of IRAK4 FL and a shift toward a monomeric molecular mass, 65.6 kDa (1.0% error) by MALS ( Figure 1D ). Similarly, dephosphorylated IRAK4 KD is also dimeric with a measured molecular mass of 57.5 kDa (0.5% error) (Figure 1D) , in comparison with the calculated monomer molecular weight of 34.8 kDa. Following treatment with ATP/Mg 2+ , autophosphorylated IRAK4 KD becomes monomeric, with an experimental molecular mass of 33.9 kDa (0.8% error) ( Figure 1D ). In order to investigate the thermodynamic parameters of IRAK4 dimerization, we performed sedimentation equilibrium analytical ultracentrifugation (SE-AUC) on IRAK4
FL-D311N at concentrations of 6.4 mM, 4.8 mM, and 2.9 mM ( Figure 1E ). Centrifugation at five speeds followed by global fitting of a monomer-dimer self-association model resulted in a measured dimerization constant (K D ) of 2.5 ± 0.4 mM, a modest affinity in protein-protein interactions.
IRAK4 trans-Autophosphorylation Is Enhanced by MyD88
The dimerization constant and the equilibrium behavior of IRAK4 during SEC suggest a dynamic dimerization that may not occur in cells in the resting state. Because IRAK4 gets recruited to the Myddosome through DD/DD interactions with MyD88, we next sought to understand the effect of MyD88 on IRAK4 autophosphorylation and therefore signaling-dependent IRAK4 activation. An in vitro assay of IRAK4 autophosphorylation would require soluble recombinant MyD88. Although MyD88 DD can form a well-defined complex when coexpressed with IRAK4 ( Figure S1A ), MyD88 DD alone has the propensity to form insoluble aggregates. Even the best-behaved construct of MyD88 (20-154), containing the DD and additional linker residues, still exhibits poor solubility and forms high molecular weight aggregates when analyzed by SEC (Figure 2A ). In the crystal structure of the ternary Myddosome DD complex , a layer of MyD88 interacts with a layer of IRAK4 using one surface while simultaneously utilizing a distinct interface to mediate MyD88 homotypic interactions ( Figure 2B ). Therefore, we postulated that the ability of MyD88 to aggregate was dependent on the interaction between these two MyD88 layers. To disrupt MyD88 self-association, we selected residues at the MyD88/MyD88 interface while leaving the MyD88/IRAK4 interface intact ( Figure 2B ). The MyD88 G80K mutation successfully disrupted aggregation as assayed by SEC (Figure 2A) . Importantly, MyD88 DD-G80K retained the ability to assemble into a high molecular weight complex with dephosphorylated IRAK4 FL ( Figure 2C ).
In order to understand the relationship between IRAK4 dimerization and activation, we performed autophosphorylation assays using [g- FL efficiently underwent rapid autophosphorylation ( Figure 2D ). The rate of autophosphorylation was highly dependent on concentration. As the concentration of IRAK4 FL was lowered below that of the dimerization K D , the rate of autophosphorylation decreased significantly ( Figure 2D ). At 500 nM, the rate of autophosphorylation is approximately 120-fold slower than that at 10 mM. The correspondence between the concentration dependence of autophosphorylation and dimerization suggests that dimerization is a prerequisite for autophosphorylation. Concentration-dependent autophosphorylation is indicative of trans-autophosphorylation rather than cis-autophosphorylation, as suggested previously from the inability of WT IRAK4 to phosphorylate a kinase-inactive mutant IRAK4 FL-K213A/K214A (Cheng et al., 2007) . However, this experiment was performed at concentrations below 400 nM for WT and mutant IRAK4, which would exhibit a negligible rate shown in the concentration series of IRAK4 autophosphorylation ( Figure 2D ). In further support of trans-autophosphorylation, WT IRAK4 FL robustly phosphorylated the kinase-inactive mutant IRAK4 KD-D311N (Figure S2B, and see below) . Addition of MyD88 DD-G80K to the reaction resulted in dramatic increases of autophosphorylation rates ( Figure 2D ). At high concentrations, the effect of MyD88 DD-G80K was subtle, resulting in MyD88 is dependent on the IRAK4 DD, as MyD88 did not interact with ( Figure S2C ) or promote the autophosphorylation of IRAK4 KD ( Figure S2D ). These data support the model in which kinase dimerization is required for efficient trans-autophosphorylation. Dimerization can be promoted either by increasing the kinase concentration above the dimerization K D or by the incorporation of IRAK4 into the oligomeric Myddosome, effectively increasing the local concentration and promoting proximity-induced autophosphorylation. The linker between IRAK4 DD and KD contains approximately 57 residues; assuming an extended linker conformation, the lower limit of the local concentration of the kinase domain in the Myddosome would be 150 mM.
The Asymmetric Enzyme-Substrate Embrace in the IRAK4 Dimer Crystal Structure We initially attempted crystallization of both IRAK4 FL-D311N alone and the IRAK4 FL-D311N /MyD88 DD complex ( Figure S1A ), with the former giving promising initial hits. However, SDS-PAGE analysis of the IRAK4 FL-D311N crystals revealed that they contained a fragment of IRAK4 that is consistent in molecular weight to the kinase domain ( Figure S3A ), suggesting that the protein had been proteolyzed in the linker between the DD and the KD during crystallization ( Figure 1A ). Given that Myddosome-induced dimerization and associated allosteric changes may be recapitulated in IRAK4 KD-D311N at the high protein concentration used in vitro, we pursued crystal optimization and structure determination of
Molecular Cell
Structure of trans-Autophosphorylating IRAK4 Dimer the IRAK4 KD-D311N dimer. Crystals of IRAK4 KD-D311N in complex with a pan-kinase inhibitor, the natural microbial alkaloid staurosporine, were obtained in space group P6 1 22, a crystal form distinct from those of WT p-IRAK4 KD reported previously (Kuglstatter et al., 2007; . The addition of staurosporine to IRAK4 KD-D311N does not induce dimerization and in fact may slightly inhibit dimer formation at low IRAK4 KD-D311N concentrations ( Figure S3D ). The structure was solved with molecular replacement and refined to a resolution of 2.65 Å ( Table 1 ). The asymmetric unit contains two kinase monomers (A and B), each with staurosporine bound in the active site ( Figure 3A) .
Remarkably, the two IRAK4 monomers form an asymmetric dimer with a conformation resembling an ''enzyme-substrate'' embrace in which monomer A acts as the enzyme and monomer B acts as the substrate ( Figure 3A ). The enzyme monomer contains an ordered DFG motif and an activation loop conformation similar to the p-IRAK4 KD structure in complex with staurosporine (Protein Data Bank [PDB] ID code 2NRY) (Figures 3B and S3B) . Therefore, the enzyme monomer adopts a conformation typical of phosphorylated active IRAK4 without the prerequisite phosphorylation. Among the three phosphorylation sites of IRAK4, T345 is the prototypical phosphoresidue required for the active kinase conformation (Kuglstatter et al., 2007; . Residue R334, which stabilizes the active conformation through its interaction with the phosphate of p-T345 in the p-IRAK4 KD structure (Kuglstatter et al., 2007; , is disordered in the enzyme monomer of the IRAK4 structure ( Figures 3B and S3B ). The other two sites at T342 and S346 are nonprototypical sites of phosphorylation and do not make crucial intramolecular interactions for maintaining the active conformation in the crystal structures of p-IRAK4 KD (Kuglstatter et al., 2007; . Although the overall conformation of the substrate monomer in the asymmetric dimer is similar to the enzyme monomer with a root-mean-square deviation (rmsd) of 0.77 Å for 248 superimposed Ca positions, part of the activation segment including the DFG motif and the activation loop showed striking differences ( Figures 3C and S3C ). In the substrate monomer, the activation loop is extended outward toward the active site of its partner, the enzyme monomer. Superposition of the enzyme monomer with the structure of phosphorylase kinase (PhK) bound to a peptide substrate shows a similarity in position and conformation between the PhK peptide substrate and the activation loop of the IRAK4 substrate monomer ( Figure 3D ), supporting the enzyme-substrate interpretation of the asymmetric IRAK4 dimer. Residues 348-350 of the enzyme monomer activation loop form an antiparallel b sheet with residues 346-348 of the substrate monomer activation loop ( Figure 3E ), consistent with the archetypal interactions involved in substrate recognition by protein kinases (Knighton et al., 1991) . Strikingly, T345 of the substrate monomer is positioned at the active site of the enzyme monomer, immediately adjacent to a bound sulfate ion in the crystal structure ( Figure 3A) . When AMP-PNP is modeled into the active site by superposition of the enzyme monomer with p-IRAK4 bound to the nucleotide (rmsd 0.30 Å ) (PDB 2OID) (Kuglstatter et al., 2007) , the g-phosphate is located in approximately the same position as this sulfate ( Figure 3F ). Additionally, T345 of the substrate kinase makes hydrogen bonds with the catalytic base residue, here mutated to N311, as well as K313 and the sulfate ion ( Figure 3A ). K313 interacts with the sulfate ion in the same manner that it uses to stabilize the negative charge of the g-phosphate of ATP. The mode of interaction of T345 with the catalytic base residue and a positively charged residue is similar to substrate recognition by the tyrosine kinases insulin receptor kinase (Hubbard, 1997) and insulin-like growth factor 1 receptor kinase (IGF1-RK) (Favelyukis et al., 2001 ). In the absence of Mg 2+ , the Mg 2+ coordinating residue D329 instead forms water-mediated hydrogen bonds with the sulfate ion. Therefore, T345 is bound in a position and environment poised for the phosphotransfer reaction. Because the residue preceding T345 is a Met (M344), we used sulfur anomalous diffraction to verify the correct placement of the substrate monomer activation loop. Highly redundant diffraction data were collected at 6 keV, where the calculated anomalous 
Structure of trans-Autophosphorylating IRAK4 Dimer scattering factor f 00 is equal to 0.95 (Table 1 ). The structure was solved by molecular replacement, and peaks in the sulfur anomalous difference Fourier density were readily apparent. Importantly, the anomalous difference map showed the location of the sulfur atom in the side chain of M344, confirming that the assignment of the activation loop is correct ( Figure 3G ).
Symmetric, Exosite IRAK4 Dimerization at the C-Terminal Lobe
The IRAK4 dimer buries 1,160 Å 2 surface area from each of the monomers, as calculated using the online program PDBePISA (Krissinel and Henrick, 2007) . In addition to the asymmetric activation loop interactions, the C-terminal lobes of the two kinases interact with each other at exosites across a noncrystallographic 2-fold symmetry axis ( Figures 3A and 4A ). The noncrystallographic 2-fold symmetry is almost perfect, with a 175.0 rotation between the two monomers. The C-terminal lobe contacts contain interactions between residues on helix aEF (the aEF exosite) and interactions between aG of one monomer and the aH-aI loop of the other monomer (the aG exosite) ( Figure 4A ). At the aEF exosite, residues L360 and R361 contribute large buried surface area through both hydrophobic and polar interactions See also Table 1 and Figure S3 .
( Figure 4B ). The interaction at the aG exosite is highly charged, consisting of the acidic aG helix surface of one monomer and basic surface of the aH-aI loop on the opposing monomer (Figures 4C and S4A) . As previously reported, helix aG exists in an unusual conformation, having swung out 10 Å away from aEF (Kuglstatter et al., 2007; . This position of aG is unique to the IRAK4 kinase and is critical for the observed dimerization interface. Analysis of residues at the dimerization interface indicates conservation among IRAK4 proteins from different species (Figure S4B) , suggesting that IRAK4 dimerization is a general feature of its activation mechanism. There is no apparent sequence similarity of the IRAK4 activation loop with a physiological IRAK4 substrate, the activation loop of IRAK1 (Hekmat-Nejad et al., 2010) . This observation suggests that the IRAK4 activation loop is not an optimal IRAK4 substrate and that the exosite interactions are needed to facilitate IRAK4 transautophosphorylation.
Mutations that Disrupt IRAK4 Dimerization Inhibit Autophosphorylation In Vitro
To test the importance of the structurally observed IRAK4 dimer, we used mutagenesis to disrupt IRAK4 dimerization and studied the effects of mutations on IRAK4 autophosphorylation. Residues L360 and R361 of the aEF helix, E401 of the aG helix, and K440 of the aH-aI loop were targeted for mutagenesis based on their buried surface area and predicted contribution to the interface. These mutations were introduced into the dimeric IRAK4 . All selected mutations disrupted dimerization when analyzed by MALS ( Figure 4D ). The more conservative mutation, L360A, was less disruptive to dimerization than the charge reversal mutations and resulted in a less monomeric phenotype. These data confirmed the observed dimerization interface in the crystal.
Mutations that disrupt IRAK4 dimerization were then tested for their effect on IRAK4 autophosphorylation. The interface mutations were introduced into WT IRAK4 KD . Each kinase mutant was purified and dephosphorylated with l-phosphatase. Autophosphorylation of these mutants was then assayed using [g-32 P]ATP ( Figure 4E ). WT IRAK4 KD showed robust autophosphorylation. IRAK4 KD-L360A was partially defective, while the charge reversal mutations R361E, E401K, and K440E resulted in either extremely low or undetectable levels of autophosphorylation. The differential severity between the L360A and charge reversal autophosphorylation phenotypes corresponds with the partial and complete dimerization disruption observed in these mutants. In addition, we introduced these mutations into the inactive IRAK4 KD-D311N construct. They were then subjected to trans-phosphorylation by WT IRAK4 FL ( Figure 4F ). Robust trans-phosphorylation was detected when phosphorylating catalytically inactive IRAK4 . However the dimerization interface mutants showed attenuated phosphorylation by WT IRAK4, suggesting that disruption of dimerization impaired the ability of IRAK4 to act as a substrate. Again, the severity of the trans-autophosphorylation phenotypes correlated with the degree of dimerization disruption. The mutational effects on autophosphorylation ( Figure 4E ) are more severe than on transphosphorylation ( Figure 4F ), likely because in autophosphorylation the dimerization interfaces on both partners in the dimer are compromised. Taken together, these data demonstrate that dimerization is necessary for IRAK4 autophosphorylation.
Disruption of IRAK4 Dimerization Results in Defective Signaling in Cells
To test whether disruption of dimerization impairs the ability of IRAK4 to perform its role in signaling, we utilized an IRAK4-deficient human fibroblast cell line derived from a patient with recurrent pyogenic infections (Picard et al., 2003) . These IRAK4-deficient human fibroblasts were reconstituted with either Flag-tagged WT human IRAK4 FL , the kinase-inactive mutant IRAK4 , IRAK4 FL-L360A , or IRAK4 FL-R361E . K213 is a critical ATP-binding residue at the N-terminal lobe, which is properly oriented for catalysis by an ion pair with the aC-helix conserved in all protein kinases (Nolen et al., 2004) . These cells were then stimulated with IL-1b, and the signaling properties were observed ( Figure 5 ). As reported previously, in comparison with IRAK4 WT , reconstitution with IRAK4 FL-K213M compromised IKK phosphorylation, IkBa degradation, and JNK phosphorylation ( Figure 5A ) due to decreased TAK1-dependent IKK and MAP kinase activation (Fraczek et al., 2008; Yao et al., 2007) . However, lack of IRAK4 kinase activity did not significantly affect IkBa phosphorylation due to an alternative MEKK3-dependent pathway that phosphorylates but does not degrade IkBa (Fraczek et al., 2008; Yao et al., 2007) . Additionally, decreases in the levels of tumor necrosis factor alpha (TNF-a) and IL-8 mRNA were observed in the IRAK4 FL-K213M reconstituted cell line ( Figures 5B and 5C ).
Remarkably, reconstitution with the dimerization-deficient mutants IRAK4 FL-L360A and IRAK4 FL-R361E resulted in phenotypes similar to those of kinase-inactive IRAK4 FL-K213M with respect to IKK and JNK phosphorylation, IkBa degradation ( Figure 5A ), as well as TNF-a ( Figure 5B ) and IL-8 mRNA expression levels ( Figure 5C ). Introduction of mutations into the IRAK4 kinase domain did not affect the interaction with MyD88 ( Figure S5 ). These data demonstrate that IRAK4 dimerization is absolutely required for IRAK4 kinase activation and the associated biological functions.
Small-and Wide-Angle X-Ray Scattering of the Myddosome We next sought to obtain structural information on the Myddosome complex containing MyD88 DD and IRAK4 FL in order to understand the positioning of the kinase domains relative to the DD core. MyD88 DD was coexpressed with IRAK4 FL-D311N in insect cells. The complex was purified to homogeneity (Figure S1A ) and subjected to SAXS/WAXS. Guinier analysis at low scattering angles indicated that the sample was free of aggregation ( Figure 6A ) and provided an estimated radius of gyration (R g ) of 64.5 ± 1.5 Å . The pair-distance distribution function (P(r)) obtained via indirect Fourier transformation possessed a bimodal shape ( Figure 6B ). The best P(r) function was obtained with a maximum linear dimension (D max ) of 212.5 Å . The R g of 64.9 ± 0.9 Å obtained through indirect transform closely approximated the estimated value obtained with Guinier analysis ( Figure 6C ). The P(r) function obtained through indirect Fourier transform was then subjected to ab initio molecular envelope calculation. A total of 20 independent models were generated from different random seed starting points. Of the 20 initial models, 1 fell outside 2 SDs and was omitted from the ensemble. The 19 remaining models were averaged and filtered to an appropriate volume. The resulting envelope contained a central core flanked by two lobes on either side ( Figure 6D ). We reasoned that the envelope represented the central DD core of the Myddosome, flanked by two IRAK4 kinase dimers. Weaker densities were observed between the central core and the flanked lobes, suggesting the location of the linker between IRAK4 DD and KD. High-resolution crystal structures were modeled into this molecular envelope. In the docked model, the N-terminal lobes of the KD dimers face toward the core DD complex. The distances between C-terminal tails of IRAK4 DDs and N-terminal residues of KDs are between 48 Å and 77 Å , which can be easily accommodated by the linker of 57 residues between the two domains. The docked model shows good agreement with experimental data ( Figures 6A and 6C) . Formation of IRAK4 KD dimers in the Myddosome supports proximity-driven dimerization and IRAK4 activation ( Figure 6E ).
Molecular Dynamics Simulations
Our mutagenesis data showed that the exosite interactions are crucial for IRAK4 dimer formation. However, direct mutagenesis of activation loop residues may lead to unforeseen effects on enzyme kinetics in addition to effects on the observed enzyme-substrate embrace. We thus turned to long-timescale MD simulations, which can reveal conformational changes on ms-ms timescales (Shaw et al., 2009) . We first simulated the asymmetric IRAK4 dimer and verified its stability over the course of the MD simulation ( Figures 7A and 7B) . We then generated a hypothetical symmetrical dimer by replacing the substrate monomer with a superimposed enzyme monomer, effectively removing the asymmetric activation loop interaction while preserving symmetric exosite interactions. MD simulations of this symmetrical dimer resulted in rapid deviations in structure, which were much more substantial than those observed in the asymmetric dimer simulations, suggesting that the activation loop interaction is important for maintaining the observed dimer configuration.
Our biochemical data established that activation loop phosphorylation dissociates IRAK4 dimers ( Figure 1D ). To deduce if T345, the canonical phosphorylation site in the activation loop of IRAK4, may be responsible for this dissociation, we simulated the stability of the enzyme-substrate-embraced dimer upon T345 phosphorylation. Consistent with our biochemical data, addition of the phosphate group to T345 induced large deviations of the substrate kinase activation loop ( Figure 7C ), suggesting that dissociation would occur at longer timescales. These data provide evidence that phosphorylation at T345 is a mechanism of IRAK4 dimer dissociation.
DISCUSSION
Kinase activities are highly regulated, and in a large subset of kinases, this regulation is implemented by phosphorylation within the activation loop (Taylor and Kornev, 2011) . In these kinases, phosphorylated residues within the activation loop mediate specific intramolecular interactions that stabilize the active kinase conformation. For many kinases, this phosphorylation event is realized by trans-autophosphorylation between two identical kinase molecules, although examples of cis-autophosphorylation are also known (Hu et al., 2013) . We hypothesize that autophosphorylating kinases sample the active conformation more frequently than their nonautophosphorylating counterparts, even in the absence of activation loop phosphorylation. Protein kinases contain a highly conserved hydrophobic regulatory spine that anchors important elements for catalysis Taylor and Kornev, 2011) . IRAK4 contains a unique gatekeeper residue Y262 (Kuglstatter et al., 2007; , which packs against the regulatory spine ( Figure 7D ) and may stabilize the active conformation. In MD simulations, mutation of the unique Y262 to Ala or common gatekeeper residues, such as Thr, Phe, or Leu, led to destabilization of the active conformation in the absence of phosphorylation ( Figure 7E ). Additionally, IRAK4
KD-Y262T is defective for in vitro autophosphorylation ( Figure 4E ) without disrupting dimerization ( Figure 4D ), and reconstitution of IRAK4-deficient human fibroblasts with IRAK4 FL-Y262T does not restore WT signaling ( Figure 5 ). Taken together, these data suggest that this unique tyrosine gatekeeper is critical for IRAK4's autophosphorylation activity. Molecular mechanisms of trans-autophosphorylation have been pursued extensively. Structurally, analysis of crystal packing has revealed that several kinases known to autophosphorylate form activation-loop-swapped, symmetrical crystallographic dimers. These include the Ser/Thr kinase TBK1, important for interferon activation in innate immunity, the DNA damage checkpoint Ser/Thr kinase CHK2, and the tyrosine kinase IGF1-RK (Cai et al., 2009; Ma et al., 2012; Wu et al., 2008) . Therefore, it has been proposed that reciprocal exchange of activation segments might be a common mechanism of transautophosphorylation (Oliver et al., 2007) , which may explain the lack of sequence similarity between activation loops and substrates. However, because neither of the active sites is fully formed in these symmetrical dimers, it raises the question of how catalysis of trans-autophosphorylation is achieved in these conformations.
Formation of unphosphorylated IRAK4 KD dimers in solution gave us the unique opportunity to unambiguously correlate the dimer interface observed in the crystal with dimerization in solution, trans-autophosphorylation in vitro with and without MyD88, and signaling in cells. Our studies led to an elegant yet simple mechanism of trans-autophosphorylation in which one kinase assumes the active enzyme conformation while the partner kinase inserts its activation loop as a substrate. Curiously, the exosite interactions in the IRAK4 dimer represent a commonly used allosteric site and likely further promote adoption of an active conformation of the enzyme kinase. For example, a similar exosite containing the aG helix is used in recognition of the substrate eIF2a by protein kinase RNA-activated (PKR) (Seo et al., 2008) (Figure S6A ). The modest dimerization constant renders IRAK4 in an inactive state at physiological concentrations and safeguards against spontaneous ligand-independent autoactivation. Recruitment of IRAK4 to MyD88 to form the Myddosome dramatically increases the local concentration of IRAK4, promoting dimerization and allosteric activation ( Figure 6E ). Addressing allosteric changes responsible for enzyme activation in oligomerization-driven biological systems remains an important and exciting challenge for structural biologists. The mode of trans-autophosphorylation elucidated here has been proposed previously for p21-activated kinases (PAKs) (Pirruccello et al., 2006) . The active conformation of IRAK4 in the absence of phosphorylation is reminiscent of PAK1, which showed an active conformation without the cognate Thr phosphorylation (Lei et al., 2005 ). An asymmetric enzyme-substrate dimer was also observed in the crystal lattice of the unphosphorylated PAK1 structure (Figure S6B ), which suggests a common mechanism of trans-autophosphorylation. Unlike the IRAK4 dimer, the exosite interactions in the PAK1 dimer are not symmetrical. In both cases, the extensive exosite interactions may facilitate the positioning of the activation loops as substrates, explaining the lack of sequence similarity between activation loops and substrates. Given the highly dynamic nature of protein kinases, it is likely that a variety of different structural features are utilized to achieve autophosphorylation.
EXPERIMENTAL PROCEDURES Cloning and Protein Purification
Human IRAK4, FL, KD, and all mutants were expressed in insect cells, while MyD88 DD MyD88 DD-G80K and IRAK4 DD were expressed in E. coli. Proteins were purified with HisPur Cobalt Resin (Thermo Scientific) followed by anion exchange and size-exclusion chromatography (Superdex 200 10/300 GL, GE Healthcare).
Multiangle Light Scattering
Samples were applied over a Superdex 200 10/300 GL column coupled to a three-angle light scattering detector (mini-DAWN TRISTAR) and a refractive index detector (Optilab DSP) (Wyatt Technology).
Sedimentation Equilibrium Analytical Ultracentrifugation IRAK4 FL-D311N was subjected to ultracentrifugation until equilibrium was reached in a Beckman Coulter Optima XL-A ultracentrifuge with an An-60 Ti rotor using six-channel centerpieces and quartz glass.
Crystallization, Data Collection, and Structure Determination IRAK4 KD-D311N was cocrystallized with staurosporine in 1.6-1.9 M ammonium sulfate and 100 mM HEPES-NaOH (pH 7). Crystals were cryoprotected and flash frozen in liquid nitrogen. Data collection was performed at the National Synchrotron Light Source (NSLS).
Kinase Assays
Dephosphorylated IRAK4 was subjected to auto-and trans-phosphorylation experiments with or without precincubation with MyD88 DD-G80K using [g- 32 P] ATP. Phosphoproteins were separated from free nucleotides by SDS-PAGE and visualized by autoradiography.
Plasmids and Retroviruses
IRAK4 WT and mutants were cloned into pMXs-IRES-Puro and transfected into Phoenix cells for viral packaging. Human IRAK4-deficient fibroblasts were infected by the packaged retrovirus, and stable viral integration was selected by puromycin.
Immunoblotting and Coimmunoprecipitation
Cell lysates were separated by 10% SDS-PAGE, transferred to Immobilon-P membranes (Millipore), and subjected to immunoblotting. For coimmunoprecipitations, cell lysates were incubated with 20 ml of protein A-Sepharose beads with anti-Flag antibody before immunoblotting.
Quantitative Real-Time PCR Total RNA was isolated using TRIzol reagent (Invitrogen) and subjected to reverse transcription using SuperScript-reverse transcriptase (Invitrogen). Quantitative PCR was performed on an AB 7300 RealTime PCR System.
Small-and Wide-Angle X-Ray Scattering Data were collected in triplicate on the IRAK4
FL-D311N /MyD88 DD complex at concentrations of 2, 1, and 0.5 mg/ml. Data were merged and scaled, followed by evaluation of the particle distance distribution function P(r) and ab initio modeling.
Molecular Dynamics Simulations
Equilibrium molecular dynamics simulations were performed on the specialpurpose molecular dynamics machine Anton (Shaw et al., 2009 ).
ACCESSION NUMBERS
The accession numbers for the data reported in this paper are 4U97 and 4U9A. Figure 3B . The canonical phosphorylated residue, pT345 of p-IRAK4 KD IRAK4-deficient human fibroblasts were infected with retroviruses containing empty vector construct (Vector), Flag-tagged IRAK4 FL wild-type (WT) and mutants (K213M, L360A, R361E, and Y262T). Cells were treated with IL-1β (1 ng/mL) for the indicated times, followed by immunoprecipitation (IP) with Flag antibody and Western blot for MyD88. Western blot of whole cell lysate (WCL) was included to control for MyD88 and Flag-IRAK4 expression levels. (A) The KD of PKR (yellow) is superimposed with the IRAK4 KD-D311N "enzyme" monomer. The PKR substrate eIF2α also interacts with the PKR αG helix. Similarly, the IRAK4 "substrate" monomer interacts with the IRAK4 "enzyme" monomer αG helix. (B) The "enzyme" monomers of PAK1 (yellow) and IRAK4
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KD-D311N (green) are superimposed. The "substrate" monomers of PAK1 (pink) and IRAK4
KD-D311N (blue) are in distinct locations, illustrating the large differences between the dimerization interfaces.
SUPPLEMENTAL EXPERIMENTAL PROCEDURES
Cloning and Protein Purification
PCR fragments of human IRAK4, FL and , were inserted into pFastBacHTB between BamHI and NotI restriction sites. Plasmids were transformed into DH10Bac™ E. coli competent cells followed by bacmid purification using the Bac-to-Bac® baculoviral expression system. Bacmids were transfected into Sf9 monolayer cells to generate baculoviruses. Harvested baculoviruses were used to infect High Five™ cells for 48 hours at 27 °C. Cells were harvested by centrifugation and resuspended in lysis buffer containing 50 mM Hepes-NaOH at pH 7.5, 300 mM NaCl, 10 mM imidazole and 1mM TCEP-HCl. DNase (10 μg/mL) and protease inhibitors (SIGMAFAST™ Protease Inhibitor Cocktail Tablets, EDTA-Free) were added to the lysate. Cells were lysed with an Avestin EmulsiFlex-C3 homogenizer. Cell debris was cleared via centrifugation at 48,400 relative centrifugal force (RCF). Clarified lysates were incubated with HisPur™ Cobalt Resin and washed extensively with lysis buffer. Bound proteins were eluted with lysis buffer supplemented with 150 mM imidazole. The eluates were immediately further purified with anion exchange chromatography using Source 15Q resin, followed by N-terminal 6xHis-tag cleavage using overnight incubation with 6xHis-TEV at 4 °C. When desired, IRAK4 was dephosphorylated via the simultaneous addition of 6xHis-λ-phosphatase and 5 mM MnCl2. Removal of TEV and λ-phosphatase was facilitated with HisPur™ Cobalt Resin and anion exchange. IRAK4 was then further purified with a final sizeexclusion chromatography (SEC) step in 20 mM Hepes-NaOH at pH 7.5, 150 mM NaCl and 1mM TCEP-HCl. Fractions containing IRAK4 were pooled, concentrated, and flash frozen in liquid N2. To generate phosphorylated IRAK4 FL and IRAK4 KD , the proteins were incubated with 5 mM ATP and 10 mM MgCl2 for 1 hour at 25 °C. Coexpression of His-IRAK4 FL-D311N and MyD88 DD (20-124) was achieved by insertion into pFastBacDual. Generation of bacmid, expression, and purification were performed as detailed above.
DNA containing MyD88 (20-154) and IRAK4 (4-106) was obtained by PCR and inserted into pET26 between NdeI and NotI restriction sites. The MyD88 G80K mutation and all IRAK4 mutations were introduced using the QuikChange II Site-Directed Mutagenesis Kit (Agilent Technologies). Plasmids were transformed into E. coli BL21-CodonPlus® (DE3)-RIPL competent cells. Cells were grown to an OD600 of 0.6, followed by induction with 0.4 mM IPTG and overnight incubation at 20 °C. Cells were resuspended, lysed, and clarified as detailed above, without the addition of DNase or protease inhibitors. MyD88 DD (20-154), MyD88 (20-154), and IRAK4 (4-106) were then purified with HisPur™ Cobalt Resin followed by sizeexclusion chromatography as detailed above.
Multi-Angle Light Scattering (MALS)
For molecular mass determination by MALS, protein samples were injected into a Superdex 200 (10/300 GL) gel filtration column (GE Healthcare) equilibrated with SEC buffer (above). The chromatography system was coupled to a three-angle light scattering detector (mini-DAWN TRISTAR) and a refractive index detector (Optilab DSP) (Wyatt Technology). Data were collected every 0.5 s with a flow rate of 0.5 mL/min. Data analysis was carried out using ASTRA V.
Sedimentation Equilibrium Analytical Ultracentrifugation (SE-AUC)
Experiments were performed in a Beckman Coulter Optima XL-A ultracentrifuge with an An-60 Ti rotor using six-channel centerpieces and quartz glass. Following SEC, IRAK4 FL-D311N was
Is the IRAK4-KD dimer observed in the crystal structure relevant in vivo? In a series of methodical biochemical and mutagenesis experiments, with corroboration from molecular dynamics simulations, Ferrao et al. showed that the interface visualized in the crystal structure indeed mediates IRAK4 dimerization and facilitates trans-autophosphorylation in solution. Furthermore, they showed that mutations in this interface mimicked the adverse effects of a kinase-dead IRAK4 in mediating downstream signaling events (NF-kB pathway) in cells.
Other results presented in this thorough study will be of interest to protein kinase and IRAK4 aficionados, for example, the stabilizing role of the atypical gatekeeper residue (tyrosine) in the back of the ATP binding pocket. They also performed small-and wide-angle X-ray scattering of the MyD88-IRAK4 core complex to generate a low-resolution structural model.
Putting it all together, Ferrao et al. provide the following scenario for IRAK4 activation (Figure 1 ). Prior to ligand engagement of TLRs or IL-1Rs, IRAK4 is in the cytosol in a monomeric state (owing to the weak kinase dimerization constant) and thus remains unphosphorylated with low basal kinase activity. Upon ligand-induced oligomerization of receptors, IRAK4 is recruited to the receptorMyD88 complex via its DD. This translocation event greatly increases the local concentration of IRAK4, which is sufficient to drive dimerization of the IRAK4 kinase domains. Reciprocal trans-autophosphorylation and activation of IRAK4 ensues, and the kinase dimer is destabilized, allowing substrates such as IRAK1 and -2 to gain access to the IRAK4 active site.
Thus, dimerization of the IRAK4 kinase domain is a critical ''tipping point'' in this cell-signaling system: too strong an interaction and IRAK4 would be activated prematurely and constitutively, and too weak an interaction would be insufficient to ensure trans-activation and signal propagation. Therefore, a cautious embrace is warranted.
